Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 8

1.

Clinical aspects and management of levodopa-induced dyskinesia.

Tambasco N, Simoni S, Marsili E, Sacchini E, Murasecco D, Cardaioli G, Rossi A, Calabresi P.

Parkinsons Dis. 2012;2012:745947. doi: 10.1155/2012/745947. Epub 2012 Jun 3.

PMID:
22701811
[PubMed]
Free PMC Article
2.

MAO-inhibitors in Parkinson's Disease.

Riederer P, Laux G.

Exp Neurobiol. 2011 Mar;20(1):1-17. doi: 10.5607/en.2011.20.1.1. Epub 2011 Mar 31.

PMID:
22110357
[PubMed]
Free PMC Article
3.

Initiation of treatment in early PD (evidences based).

[No authors listed]

Ann Indian Acad Neurol. 2011 Jul;14(Suppl 1):S6-S10. No abstract available.

PMID:
21847330
[PubMed]
Free PMC Article
4.

Seniors with Parkinson's disease: initial medical treatment.

Ahlskog JE.

J Clin Neurol. 2010 Dec;6(4):159-66. doi: 10.3988/jcn.2010.6.4.159. Epub 2010 Dec 31.

PMID:
21264196
[PubMed]
Free PMC Article
5.

Improving symptom control in early Parkinson's disease.

Isaacson SH, Hauser RA.

Ther Adv Neurol Disord. 2009 Nov;2(6):29-41. doi: 10.1177/1756285609339383.

PMID:
21180628
[PubMed]
Free PMC Article
6.

Neuroprotective therapy in Parkinson's disease: current status and new directions from experimental and genetic clues.

Lin W, Kang UJ.

J Clin Neurol. 2005 Oct;1(2):107-20. doi: 10.3988/jcn.2005.1.2.107. Epub 2005 Oct 20.

PMID:
20396458
[PubMed]
Free PMC Article
7.

Rasagiline, Parkinson neuroprotection, and delayed-start trials: still no satisfaction?

Ahlskog JE, Uitti RJ.

Neurology. 2010 Apr 6;74(14):1143-8. doi: 10.1212/WNL.0b013e3181d7d8e2. Review.

PMID:
20368634
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Role of rasagiline in treating Parkinson's disease: Effect on disease progression.

Malaty IA, Fernandez HH.

Ther Clin Risk Manag. 2009 Aug;5(4):413-9. Epub 2009 Jun 4.

PMID:
19753135
[PubMed]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk